华海药业托拉塞米注射液获批上市用于水肿患者

新京报网03-23

新京报讯（记者刘旭）3月22日晚，华海药业发布公告，托拉塞米注射液收到国家药品监督管理局核准签发的《药品注册证书》，并视同通过一致性评价。托拉塞米注射液用于治疗需要迅速利尿或不能口服利尿剂的充血性心力衰竭、肝硬化腹水、肾脏疾病所致的水肿患者。托拉塞米注射液最早由Berlin-Chemie AG研发，1991年12月在欧盟上市，原研未在国内上市。截至目前，国内获得该药品注册证书的生产厂家主要有南京...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2421351246?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-23 22:28","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2421351246","market":"sh","top_or_hot":-1,"title":"华海药业托拉塞米注射液获批上市 用于水肿患者","media":"新京报网","content":"<div>\n<p>新京报讯（记者刘旭）3月22日晚，华海药业发布公告，托拉塞米注射液收到国家药品监督管理局核准签发的《药品注册证书》，并视同通过一致性评价。托拉塞米注射液用于治疗需要迅速利尿或不能口服利尿剂的充血性心力衰竭、肝硬化腹水、肾脏疾病所致的水肿患者。托拉塞米注射液最早由Berlin-Chemie AG研发，1991年12月在欧盟上市，原研未在国内上市。截至目前，国内获得该药品注册证书的生产厂家主要有南京...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403232229037a4e9996&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>华海药业托拉塞米注射液获批上市 用于水肿患者</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n华海药业托拉塞米注射液获批上市 用于水肿患者\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-23 22:28 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403232229037a4e9996&s=b><strong>新京报网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>新京报讯（记者刘旭）3月22日晚，华海药业发布公告，托拉塞米注射液收到国家药品监督管理局核准签发的《药品注册证书》，并视同通过一致性评价。托拉塞米注射液用于治疗需要迅速利尿或不能口服利尿剂的充血性心力衰竭、肝硬化腹水、肾脏疾病所致的水肿患者。托拉塞米注射液最早由Berlin-Chemie AG研发，1991年12月在欧盟上市，原研未在国内上市。截至目前，国内获得该药品注册证书的生产厂家主要有南京...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403232229037a4e9996&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0185","symbol_name":"二线龙头","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403232229037a4e9996&s=b","article_id":"2421351246","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403232229037a4e9996&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2421351246","pubTimestamp":1711204080,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"新京报讯（记者刘旭）3月22日晚，华海药业发布公告，托拉塞米注射液收到国家药品监督管理局核准签发的《药品注册证书》，并视同通过一致性评价。托拉塞米注射液用于治疗需要迅速利尿或不能口服利尿剂的充血性心力衰竭、肝硬化腹水、肾脏疾病所致的水肿患者。托拉塞米注射液最早由Berlin-Chemie AG研发，1991年12月在欧盟上市，原研未在国内上市。截至目前，国内获得该药品注册证书的生产厂家主要有南京优科制药、扬子江药业、山西普德药业、南京臣功制药等。米内网数据显示，托拉塞米注射液2022年国内市场销售金额约人民币4.75亿元。校对 卢茜","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600521":"华海药业","BK0185":"二线龙头","BK0012":"证金概念","BK0188":"融资融券","BK0070":"员工持股","BK0028":"国家队","BK0201":"可转债","BK0239":"医药制造"},"translate_title":"Huahai Pharmaceutical Torasemide Injection was approved for marketing for edema patients","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600521":0.9},"content_text":"新京报讯（记者刘旭）3月22日晚，华海药业发布公告，托拉塞米注射液收到国家药品监督管理局核准签发的《药品注册证书》，并视同通过一致性评价。托拉塞米注射液用于治疗需要迅速利尿或不能口服利尿剂的充血性心力衰竭、肝硬化腹水、肾脏疾病所致的水肿患者。托拉塞米注射液最早由Berlin-Chemie AG研发，1991年12月在欧盟上市，原研未在国内上市。截至目前，国内获得该药品注册证书的生产厂家主要有南京优科制药、扬子江药业、山西普德药业、南京臣功制药等。米内网数据显示，托拉塞米注射液2022年国内市场销售金额约人民币4.75亿元。校对 卢茜","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2421351246"}

华海药业托拉塞米注射液获批上市 用于水肿患者

精彩评论

华海药业托拉塞米注射液获批上市用于水肿患者